A clinical prediction model for rapidly differentiating pulmonary tuberculosis from community acquired pneumonia in
Chunjiao Han1,2, Yulian Fang2, Lili Dong1,3
1Clinical School of Pediatrics, Tianjin Medical University, Tianjin, China.
Insights
Diagnosing pediatric pulmonary tuberculosis (PTB) is challenging. This study developed a simple clinical prediction model using patient history and symptoms, showing good accuracy for empirical PTB diagnosis in children.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Clinical Diagnostics
Background:
- Diagnosing pediatric pulmonary tuberculosis (PTB) presents significant challenges due to non-specific symptoms.
- Microbiological confirmation is often absent, complicating clinical decision-making.
Purpose of the Study:
- To develop a simple clinical prediction model for the empirical diagnosis of PTB in children.
- To identify key clinical symptoms and medical history factors for predicting pediatric PTB.
Main Methods:
- Retrospective analysis of clinical and laboratory data from children diagnosed with PTB or community-acquired pneumonia (CAP).
- Logistic analysis was used to identify independent risk factors and construct a predictive model.
- The model was validated using a separate patient cohort.
Main Results:
- A nomogram incorporating basic disease, tuberculosis contact history, maximum body temperature, and weight loss was developed.
- The model demonstrated good diagnostic performance in both modeling (AUC: 0.810) and validation (AUC: 0.864) groups.
- Decision curve and calibration analyses confirmed the model's clinical practicality and accuracy.
Conclusions:
- A validated nomogram for predicting pediatric PTB was successfully developed.
- The nomogram shows promising clinical performance for the empirical diagnosis of PTB in children.
- This tool may aid clinicians in diagnosing pediatric PTB more effectively.
Background:
Due to the non-specific symptoms of pulmonary tuberculosis (PTB) in children, the diagnosis of PTB in children is a major challenge for clinicians in the absence of microbiological confirmation. This study aims to construct a simple clinical prediction model for empiric diagnosis of PTB through careful clinical symptoms and medical history.
Methods:
Retrospective analysis of clinical data and laboratory data of children with PTB and community acquired pneumonia (CAP) diagnosed at Tianjin Children's Hospital from January 2018 to October 2023. All patients were randomly divided into a 7:3 ratio into a modeling group and a validation group. The modeling group was used to perform logistic analysis to identify independent risk factors and construct a clinical prediction model for PTB in children. The validation group was used to further assess the clinical efficacy of the model.
Results:
A total of 434 children were included in this study. The modeling group included 305 patients (125 with PTB, 180 with CAP) and validation group included 129 patients (53 with PTB, 76 with CAP). Four variables including basic disease, tuberculosis contact history, maximum body temperature and weight loss were identified as potential predictors used for developing a nomogram. The nomogram showed a good diagnostic performance in the modeling group [area under the curve (AUC) (95% confidence interval (CI)), 0.810(0.759 ~ 0.860)]. The decision curve analysis (DCA) and calibration curve indicated that the clinical prediction model for pediatric PTB has good clinical practicality and accuracy. The validation group also showed good clinical efficacy [AUC (95%CI), 0.864(0.794 ~ 0.934)], indicating that the model is feasible and reproducible.
Conclusions:
This study developed and validated a nomogram for predicting PTB in children. This nomogram represents good clinical performance and might be utilized clinically in the empirical diagnosis of PTB in children.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...


